Removing abnormal synovium decreases the tissue available to produce inflammatory mediators, which can sustain swelling, pain, and progressive tissue damage. The benefit therefore comes from reducing an active source of inflammation rather than simply removing excess tissue. This mechanism is especially relevant when persistent synovial disease continues despite medical treatment and interferes with joint function.
The two approaches remove diseased synovium through different surgical access methods. Open surgery provides direct access through an incision, whereas arthroscopy uses a minimally invasive approach. The overview does not specify that one method is universally superior, so the choice depends on the location and extent of synovial involvement, the underlying disorder, and the treating team's assessment.
Synovectomy addresses diseased synovium, but it does not eliminate every cause of joint inflammation or bleeding. Outcomes therefore depend on the underlying condition and how extensively the synovium is involved. Patients may experience improved function and reduced symptoms, yet the expected benefit can vary when the disease process is widespread or continues to affect the joint after surgery.
It may be considered when medication has not adequately controlled clinically important synovial disease. Supported indications include inflammatory arthritis, recurrent bleeding into a joint, and selected proliferative synovial disorders. In these settings, surgery is used as a management option for persistent swelling, pain, or tissue injury rather than as a routine replacement for medical therapy.
The excised synovium can be submitted for pathological analysis, allowing clinicians to examine the tissue and help characterize the disorder causing the synovial abnormality. This diagnostic value complements the therapeutic goal of reducing diseased tissue. Pathological assessment is particularly relevant when a proliferative synovial disorder is being considered or when the tissue's nature requires clarification.
The procedure may be used in selected cases involving inflammatory arthritis, recurrent hemarthrosis, or proliferative synovial disorders. Synovial disease can occur in the lining of a joint, a tendon sheath, or a bursa, so the relevant surgical site is determined by where the abnormal tissue is located. The potential outcome includes symptom relief and improved function.